Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populationsM. Geoffrey Hayes, J.C. Trussell, Cecilia M. Lindgren et al.|Nature Communications|2015Cited by 542
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH AntagonistHugh S. Taylor, Kristof Chwalisż, Linda C. Giudice et al.|New England Journal of Medicine|2017Cited by 492
Long-Term Outcomes of Elagolix in Women With EndometriosisEric S. Surrey, Kristof Chwalisż, Hugh S. Taylor et al.|Obstetrics and Gynecology|2018Cited by 132
Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled StudyMichael P. Diamond, Kristof Chwalisż, Bruce R. Carr et al.|Reproductive Sciences|2013Cited by 120
Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral DensityBruce R. Carr, Kristof Chwalisż, W. Paul Dmowski et al.|Reproductive Sciences|2014Cited by 113